Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$1.14 - $1.87 $119,420 - $195,891
-104,755 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$1.34 - $3.53 $3,852 - $10,148
2,875 Added 2.82%
104,755 $186,000
Q4 2020

Feb 16, 2021

BUY
$0.87 - $1.26 $7,631 - $11,052
8,772 Added 9.42%
101,880 $124,000
Q3 2020

Nov 17, 2020

BUY
$0.93 - $1.35 $1,096 - $1,591
1,179 Added 1.28%
93,108 $91,000
Q1 2020

May 13, 2020

BUY
$0.9 - $1.95 $945 - $2,049
1,051 Added 1.16%
91,929 $101,000
Q2 2019

Aug 14, 2019

SELL
$0.96 - $1.89 $68,979 - $135,804
-71,854 Reduced 44.15%
90,878 $111,000
Q4 2018

Feb 13, 2019

BUY
$2.01 - $4.21 $197,872 - $414,449
98,444 Added 153.13%
162,732 $600,000
Q2 2018

Aug 14, 2018

BUY
$2.05 - $4.09 $131,790 - $262,937
64,288 New
64,288 $203,000

About TYME TECHNOLOGIES, INC.


  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.